We studied the performance of cod rearing in which live feed was given under three different essential fatty acid (EFA) enrichment regimes, using commercially available live-feed enrichments. We assessed the fatty acid profile [docosahexaenoic (DHA), eicosapentaenoic (EPA), and arachidonic acid (AA)] in larval somatic tissue, relative to its amounts in both rotifers and Artemia as well as to larval performance. Overall, percentage lipid level of each experimental diet for the trial was approximately 50%. Further, there were no significant differences in total fatty acid levels of larvae from each treatment at the end of the trial (mean = 444.76 μg fatty acid per mg lipid). However, during the rotifer phase, larvae from each treatment were able to incorporate comparable levels of %DHA, irrespective of levels in the diet. Despite this, the rotifer diet with more %DHA still promoted better larval growth than other treatments. Conversely, larvae from two of the treatments did not exhibit any accumulation of AA, reflecting levels found in the diet instead. However, between-tank differences in larval %AA showed improved growth during the rotifer period when larval %AA was high. Low ratios of EPA had no effect. During the Artemia phase, percentage levels of larval DHA decreased; there was no accumulation of DHA relative to dietary levels, which in Artemia were significantly lower than in rotifers (6 cf. 20–30%). However, DHA levels in larvae at the end of the experiment correlated positively with survival. Artemia contained lower levels of AA than rotifers (1.5 cf. 3.0%), yet comparable levels of AA were found in rotifer-fed and Artemia-fed larvae. This also differed significantly between treatments, and correlated positively with survival.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.